Stem Cell Research Funding Upheld

A US Appeal court rules that the National Institutes of Health is legally allowed to fund human embryonic stem cell research.

Written byHayley Dunning
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The decision by the US Court of Appeals for the District of Columbia Circuit confirms a previous ruling by a lower court, which threw out a lawsuit accusing the National Institutes of Health (NIH) of violating a 1996 law prohibiting taxpayer funding of research that destroys human embryos.

NIH funding of human embryonic stem cell (hESC) research hinges on ambiguity in the 1996 Dickey-Wicker law, which "permits federal funding of research projects that utilize already-derived ESCs—which are not themselves embryos—because no ‘human embryo or embryos are destroyed’ in such projects,” Chief Judge David B. Sentelle said in today's ruling.

The lawsuit was brought by two adult stem cell researchers, whose lawyers said today that their clients are considering taking the issue to the US Supreme Court. Although the Supreme Court accepts only about 1 percent of cases, experts say the fact that the three judges involved in this decision ruled ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies